This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Mayo Foundation for Medical Education and Research. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Ruth Lupu: Innovator in Fibrosis Treatment
Introduction
Ruth Lupu is a prominent inventor based in Rochester, MN (US). She has made significant contributions to the field of medical research, particularly in the treatment of fibrosis. Her innovative work focuses on utilizing fatty acid synthase inhibitors to address this challenging condition.
Latest Patents
Ruth Lupu holds 1 patent for her invention titled "Using fatty acid synthase inhibitors to treat fibrosis." This patent relates to materials and methods for treating fibrosis, including pulmonary fibrosis. The document outlines methods for employing one or more fatty acid synthase (FASN) inhibitors to treat mammals suffering from fibrosis and complications associated with it, such as hypoxia caused by pulmonary fibrosis.
Career Highlights
Ruth Lupu is affiliated with the Mayo Foundation for Medical Education and Research, where she continues to advance her research and innovations. Her work has the potential to significantly impact the treatment options available for patients with fibrosis.
Collaborations
Ruth has collaborated with notable colleagues, including Edward B. Leof and Jeong-Han Kang, enhancing the scope and depth of her research endeavors.
Conclusion
Ruth Lupu's contributions to the field of fibrosis treatment through her innovative patent demonstrate her commitment to advancing medical science. Her work not only highlights her expertise but also offers hope for improved therapies for patients suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile